Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

NEW TREATMENT COULD ERADICATE AIDS

by Ben Daviss

A multidisciplinary team of medical scientists from the University of Nebraska and Temple University’s medical school have, for the first time, eradicated the HIV virus from infected animals.

HIV is the virus that causes AIDS.

The infection has been incurable, in part, because HIV weaves its own DNA into that of host organisms, where it hides. Drugs have been able to suppress HIV’s genetic expression, but that only holds the symptoms at bay. Gene editing has been able to snip out some portions of HIV DNA, but the technique is imprecise and it doesn’t remove the infection or cure AIDS.

The new approach combines the latest in gene editing skills with long-acting, slow-release anti-HIV drugs with a new chemical structure. The new drugs are crafted as nanocrystals that target cells where HIV is likely to lurk. Once there, the drugs linger for weeks, suppressing HIV’s ability to replicate while state-of-the-art gene editing continued to find and eradicate HIV’s DNA.

Used in mice, the combination treatment eradicated HIV virus in about a third of the animals.
Researchers think that human clinical trials could begin by 2021.

TRENDPOST: Genetic engineering and more sophisticated drugs will turn HIV into a curable infection by 2025.